nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—AGTR1—pancreatic cancer	0.818	1	CbGaD
Tasosartan—CYP3A4—Tamoxifen—pancreatic cancer	0.00687	0.24	CbGbCtD
Tasosartan—CYP3A4—Erlotinib—pancreatic cancer	0.00585	0.204	CbGbCtD
Tasosartan—CYP3A4—Irinotecan—pancreatic cancer	0.00528	0.185	CbGbCtD
Tasosartan—CYP3A4—Docetaxel—pancreatic cancer	0.00387	0.135	CbGbCtD
Tasosartan—CYP3A4—Sunitinib—pancreatic cancer	0.00385	0.135	CbGbCtD
Tasosartan—CYP3A4—Doxorubicin—pancreatic cancer	0.00288	0.101	CbGbCtD
Tasosartan—Azilsartan medoxomil—AGTR1—pancreatic cancer	0.00222	0.258	CrCbGaD
Tasosartan—Forasartan—AGTR1—pancreatic cancer	0.00207	0.24	CrCbGaD
Tasosartan—Valsartan—AGTR1—pancreatic cancer	0.00108	0.126	CrCbGaD
Tasosartan—Olmesartan—AGTR1—pancreatic cancer	0.00106	0.123	CrCbGaD
Tasosartan—Irbesartan—AGTR1—pancreatic cancer	0.000822	0.0956	CrCbGaD
Tasosartan—Candesartan—AGTR1—pancreatic cancer	0.000822	0.0956	CrCbGaD
Tasosartan—Losartan—AGTR1—pancreatic cancer	0.00053	0.0616	CrCbGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000243	0.00167	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—GCG—pancreatic cancer	0.000239	0.00165	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—pancreatic cancer	0.000239	0.00164	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CXCL8—pancreatic cancer	0.000238	0.00164	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—DTX4—pancreatic cancer	0.000229	0.00158	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GLI1—pancreatic cancer	0.000229	0.00158	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000228	0.00157	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CASP3—pancreatic cancer	0.000228	0.00157	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CNR1—pancreatic cancer	0.000225	0.00155	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NRP1—pancreatic cancer	0.000223	0.00154	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000223	0.00154	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CNR1—pancreatic cancer	0.000219	0.00151	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—pancreatic cancer	0.000218	0.0015	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—GCG—pancreatic cancer	0.000217	0.00149	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HEY2—pancreatic cancer	0.000215	0.00148	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—SCT—pancreatic cancer	0.000214	0.00147	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GAST—pancreatic cancer	0.00021	0.00144	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000207	0.00143	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCK—pancreatic cancer	0.000204	0.0014	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—SST—pancreatic cancer	0.000203	0.0014	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SCT—pancreatic cancer	0.000199	0.00137	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HEY1—pancreatic cancer	0.000199	0.00137	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CNR2—pancreatic cancer	0.000199	0.00137	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—GLP1R—pancreatic cancer	0.000199	0.00137	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCKAR—pancreatic cancer	0.000196	0.00135	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—VEGFA—pancreatic cancer	0.000193	0.00133	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCK—pancreatic cancer	0.00019	0.00131	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	0.000187	0.00129	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CNR2—pancreatic cancer	0.000185	0.00127	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GLP1R—pancreatic cancer	0.000185	0.00127	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000185	0.00127	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCKAR—pancreatic cancer	0.000182	0.00125	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—SHH—pancreatic cancer	0.000178	0.00123	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—pancreatic cancer	0.000178	0.00122	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PRLHR—pancreatic cancer	0.000178	0.00122	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TGFB1—pancreatic cancer	0.000177	0.00122	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—JAG2—pancreatic cancer	0.000176	0.00121	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—IAPP—pancreatic cancer	0.000176	0.00121	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MEN1—pancreatic cancer	0.000174	0.0012	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—PTHLH—pancreatic cancer	0.000169	0.00116	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—PTCH1—pancreatic cancer	0.000169	0.00116	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—SSTR3—pancreatic cancer	0.000166	0.00115	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SHH—pancreatic cancer	0.000166	0.00114	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TNF—pancreatic cancer	0.000166	0.00114	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NOTCH4—pancreatic cancer	0.000165	0.00114	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IAPP—pancreatic cancer	0.000164	0.00113	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GDI2—pancreatic cancer	0.000163	0.00112	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GDI1—pancreatic cancer	0.000163	0.00112	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—SSTR1—pancreatic cancer	0.000159	0.0011	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PTHLH—pancreatic cancer	0.000157	0.00108	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PTCH1—pancreatic cancer	0.000157	0.00108	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PPY—pancreatic cancer	0.000156	0.00108	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—SST—pancreatic cancer	0.000155	0.00106	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000153	0.00106	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—SSTR3—pancreatic cancer	0.000151	0.00104	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000148	0.00102	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—SSTR1—pancreatic cancer	0.000145	0.000997	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SST—pancreatic cancer	0.000144	0.00099	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CNR1—pancreatic cancer	0.000143	0.000982	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PPY—pancreatic cancer	0.000142	0.000978	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000142	0.000977	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—JAG1—pancreatic cancer	0.000141	0.000969	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NOTCH3—pancreatic cancer	0.00014	0.000965	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—SSTR2—pancreatic cancer	0.000139	0.00096	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—GCG—pancreatic cancer	0.000138	0.000949	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCKBR—pancreatic cancer	0.000135	0.000927	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CNR1—pancreatic cancer	0.000133	0.000914	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000129	0.000887	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GCG—pancreatic cancer	0.000128	0.000883	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GAST—pancreatic cancer	0.000127	0.000878	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000125	0.000859	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AGTR1—pancreatic cancer	0.000122	0.000842	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—SCT—pancreatic cancer	0.000121	0.000832	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—STK11—pancreatic cancer	0.000121	0.00083	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CXCL8—pancreatic cancer	0.000118	0.000812	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GAST—pancreatic cancer	0.000116	0.000797	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCK—pancreatic cancer	0.000115	0.000794	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000113	0.00078	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000112	0.000773	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CNR2—pancreatic cancer	0.000112	0.000773	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000111	0.000762	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000111	0.000761	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—SCT—pancreatic cancer	0.00011	0.000756	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000109	0.000748	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SMAD4—pancreatic cancer	0.000106	0.000727	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRLHR—pancreatic cancer	0.000105	0.000722	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCK—pancreatic cancer	0.000105	0.000721	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000104	0.000719	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HES1—pancreatic cancer	0.000103	0.00071	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CNR2—pancreatic cancer	0.000102	0.000702	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GLP1R—pancreatic cancer	0.000102	0.000702	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCKAR—pancreatic cancer	0.0001	0.000691	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IAPP—pancreatic cancer	9.95e-05	0.000685	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CB—pancreatic cancer	9.87e-05	0.00068	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ZNRF3—pancreatic cancer	9.87e-05	0.000679	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ACVR1B—pancreatic cancer	9.87e-05	0.000679	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PTHLH—pancreatic cancer	9.55e-05	0.000658	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CXCL8—pancreatic cancer	9.49e-05	0.000653	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—SHH—pancreatic cancer	9.15e-05	0.00063	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IAPP—pancreatic cancer	9.04e-05	0.000622	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TERT—pancreatic cancer	9.03e-05	0.000622	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SSTR3—pancreatic cancer	8.92e-05	0.000614	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DTX1—pancreatic cancer	8.92e-05	0.000614	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—SST—pancreatic cancer	8.74e-05	0.000602	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PTHLH—pancreatic cancer	8.68e-05	0.000597	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PTCH1—pancreatic cancer	8.68e-05	0.000597	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HIF1A—pancreatic cancer	8.64e-05	0.000595	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TSC2—pancreatic cancer	8.62e-05	0.000593	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	8.57e-05	0.00059	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SSTR1—pancreatic cancer	8.55e-05	0.000589	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APOE—pancreatic cancer	8.43e-05	0.000581	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PPY—pancreatic cancer	8.39e-05	0.000578	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KDR—pancreatic cancer	8.26e-05	0.000569	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SSTR2—pancreatic cancer	8.23e-05	0.000567	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CNR1—pancreatic cancer	8.06e-05	0.000555	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCKBR—pancreatic cancer	7.95e-05	0.000548	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—SST—pancreatic cancer	7.93e-05	0.000546	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	7.91e-05	0.000545	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NFKBIA—pancreatic cancer	7.86e-05	0.000541	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	7.81e-05	0.000538	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GCG—pancreatic cancer	7.79e-05	0.000536	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NOTCH1—pancreatic cancer	7.78e-05	0.000536	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CG—pancreatic cancer	7.61e-05	0.000524	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—NRAS—pancreatic cancer	7.61e-05	0.000524	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—PIK3CA—pancreatic cancer	7.58e-05	0.000522	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EGF—pancreatic cancer	7.52e-05	0.000518	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DTX4—pancreatic cancer	7.48e-05	0.000515	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GLI1—pancreatic cancer	7.48e-05	0.000515	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	7.38e-05	0.000508	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CNR1—pancreatic cancer	7.32e-05	0.000504	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PPP2R5B—pancreatic cancer	7.27e-05	0.000501	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NRP1—pancreatic cancer	7.27e-05	0.000501	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GCG—pancreatic cancer	7.07e-05	0.000487	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HEY2—pancreatic cancer	7e-05	0.000482	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—EGFR—pancreatic cancer	6.93e-05	0.000477	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GAST—pancreatic cancer	6.84e-05	0.000471	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	6.78e-05	0.000467	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CD—pancreatic cancer	6.69e-05	0.000461	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.63e-05	0.000456	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—KRAS—pancreatic cancer	6.55e-05	0.000451	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SCT—pancreatic cancer	6.48e-05	0.000446	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HEY1—pancreatic cancer	6.48e-05	0.000446	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	6.27e-05	0.000432	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCK—pancreatic cancer	6.18e-05	0.000426	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CNR2—pancreatic cancer	6.03e-05	0.000415	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GLP1R—pancreatic cancer	6.03e-05	0.000415	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCL8—pancreatic cancer	6.02e-05	0.000415	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CA—pancreatic cancer	6.02e-05	0.000414	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCKAR—pancreatic cancer	5.93e-05	0.000408	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CB—pancreatic cancer	5.83e-05	0.000401	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JAG2—pancreatic cancer	5.75e-05	0.000396	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MEN1—pancreatic cancer	5.67e-05	0.00039	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCL8—pancreatic cancer	5.6e-05	0.000386	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—HRAS—pancreatic cancer	5.57e-05	0.000383	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—AKT1—pancreatic cancer	5.41e-05	0.000373	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SHH—pancreatic cancer	5.41e-05	0.000372	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOTCH4—pancreatic cancer	5.37e-05	0.00037	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CASP3—pancreatic cancer	5.36e-05	0.000369	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IAPP—pancreatic cancer	5.34e-05	0.000368	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCND1—pancreatic cancer	5.22e-05	0.000359	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CTNNB1—pancreatic cancer	5.17e-05	0.000356	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTHLH—pancreatic cancer	5.12e-05	0.000353	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTCH1—pancreatic cancer	5.12e-05	0.000353	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MMP9—pancreatic cancer	5.07e-05	0.000349	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PTEN—pancreatic cancer	5.04e-05	0.000347	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—AKT1—pancreatic cancer	4.92e-05	0.000338	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SST—pancreatic cancer	4.69e-05	0.000323	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SRC—pancreatic cancer	4.67e-05	0.000322	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CG—pancreatic cancer	4.62e-05	0.000318	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JAG1—pancreatic cancer	4.59e-05	0.000316	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOTCH3—pancreatic cancer	4.57e-05	0.000314	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—VEGFA—pancreatic cancer	4.55e-05	0.000313	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—STAT3—pancreatic cancer	4.51e-05	0.00031	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NRAS—pancreatic cancer	4.5e-05	0.00031	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CNR1—pancreatic cancer	4.33e-05	0.000298	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CG—pancreatic cancer	4.2e-05	0.000289	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MYC—pancreatic cancer	4.19e-05	0.000288	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GCG—pancreatic cancer	4.18e-05	0.000288	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TGFB1—pancreatic cancer	4.18e-05	0.000288	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EGFR—pancreatic cancer	4.1e-05	0.000282	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.06e-05	0.00028	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STK11—pancreatic cancer	3.93e-05	0.00027	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KRAS—pancreatic cancer	3.87e-05	0.000266	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CD—pancreatic cancer	3.69e-05	0.000254	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CA—pancreatic cancer	3.56e-05	0.000245	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.54e-05	0.000244	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SMAD4—pancreatic cancer	3.44e-05	0.000237	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TP53—pancreatic cancer	3.44e-05	0.000237	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL8—pancreatic cancer	3.4e-05	0.000234	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HES1—pancreatic cancer	3.36e-05	0.000231	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HRAS—pancreatic cancer	3.29e-05	0.000226	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CB—pancreatic cancer	3.22e-05	0.000221	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL8—pancreatic cancer	3.09e-05	0.000213	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TERT—pancreatic cancer	2.94e-05	0.000203	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AKT1—pancreatic cancer	2.9e-05	0.0002	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HIF1A—pancreatic cancer	2.81e-05	0.000194	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TSC2—pancreatic cancer	2.81e-05	0.000193	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APOE—pancreatic cancer	2.75e-05	0.000189	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KDR—pancreatic cancer	2.69e-05	0.000185	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NFKBIA—pancreatic cancer	2.56e-05	0.000176	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOTCH1—pancreatic cancer	2.54e-05	0.000175	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CG—pancreatic cancer	2.48e-05	0.000171	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—NRAS—pancreatic cancer	2.48e-05	0.000171	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EGF—pancreatic cancer	2.45e-05	0.000169	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EGFR—pancreatic cancer	2.26e-05	0.000156	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CD—pancreatic cancer	2.18e-05	0.00015	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.16e-05	0.000149	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—KRAS—pancreatic cancer	2.13e-05	0.000147	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.13e-05	0.000147	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.96e-05	0.000135	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CB—pancreatic cancer	1.9e-05	0.000131	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.85e-05	0.000127	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL8—pancreatic cancer	1.83e-05	0.000126	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HRAS—pancreatic cancer	1.81e-05	0.000125	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKT1—pancreatic cancer	1.76e-05	0.000121	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CASP3—pancreatic cancer	1.75e-05	0.00012	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCND1—pancreatic cancer	1.7e-05	0.000117	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CTNNB1—pancreatic cancer	1.68e-05	0.000116	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP9—pancreatic cancer	1.65e-05	0.000114	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTEN—pancreatic cancer	1.64e-05	0.000113	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.62e-05	0.000111	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKT1—pancreatic cancer	1.6e-05	0.00011	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SRC—pancreatic cancer	1.52e-05	0.000105	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VEGFA—pancreatic cancer	1.48e-05	0.000102	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STAT3—pancreatic cancer	1.47e-05	0.000101	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NRAS—pancreatic cancer	1.46e-05	0.000101	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MYC—pancreatic cancer	1.36e-05	9.39e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TGFB1—pancreatic cancer	1.36e-05	9.37e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EGFR—pancreatic cancer	1.33e-05	9.19e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.3e-05	8.97e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.28e-05	8.83e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KRAS—pancreatic cancer	1.26e-05	8.68e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.22e-05	8.38e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CA—pancreatic cancer	1.16e-05	7.97e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TP53—pancreatic cancer	1.12e-05	7.71e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HRAS—pancreatic cancer	1.07e-05	7.38e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKT1—pancreatic cancer	9.46e-06	6.51e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CD44—pancreatic cancer	9.42e-06	6.49e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GCG—pancreatic cancer	9.03e-06	6.22e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—STK11—pancreatic cancer	8.49e-06	5.85e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TYMS—pancreatic cancer	7.31e-06	5.03e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—APOE—pancreatic cancer	5.94e-06	4.09e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.36e-06	3.69e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARG—pancreatic cancer	5.18e-06	3.56e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.71e-06	3.25e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	4.11e-06	2.83e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—pancreatic cancer	4.07e-06	2.8e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.55e-06	2.44e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.5e-06	1.72e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.05e-06	1.41e-05	CbGpPWpGaD
